Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Vyome Holdings, Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 15 | 17 | +2 |
| Shares | 1.16M | 1.23M | +68.9K (+5.9%) |
| Value | $1.91M | $1.45M | −$455.0K (−23.9%) |
New holders (4)
Institutions that held Vyome Holdings, Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 36,490 | $43.0K | 0.01% |
| Citadel Advisors LLC | 32,562 | $38.0K | 0.00% |
| Susquehanna International Group, LLP | 10,513 | $12.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,599 | $7.00K | 0.00% |
Sold out (2)
Institutions that held Vyome Holdings, Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Millennium Management LLC | 33,713 | $55.0K |
| Signaturefd, LLC | 8,000 | $13.0K |